Services

University, Translational, and Startup Support

For academic teams, translational programs, and early-stage startups preparing technologies for funding, partnership, or development.

• Discovery-to-development roadmapping

  Defining the next technical steps needed to move promising research toward a credible development path, including practical roadmaps that connect technical milestones, decision points, and priority experiments.

• Development risk and data-gap assessment

  Identifying formulation, delivery, manufacturability, stability, scalability, and translational risks early, before they become costly barriers to progress.

• Translational grant support

  Supporting SBIR, STTR, MII, TEDCO, and related applications by strengthening technical plans, milestone structure, feasibility arguments, and development rationale.

• Commercialization and partner-readiness strategy

  Helping teams clarify product potential, technical differentiation, development risks, and evidence gaps before engaging investors, partners, accelerators, or translational funding groups.

Growth-Stage and Established Company Support

For university spinouts, growth-stage biotechs, established pharma companies, platform companies, CRO/CDMOs, and organizations expanding into new modalities or delivery technologies.

• Capability expansion and modality support

  Helping organizations enter or expand in advanced modalities, including mRNA/LNP products, nanoparticle-enabled therapies, biologics, vaccines, and other complex platforms, with focused guidance on delivery, formulation, drug product strategy, and early CMC planning.

• Early CMC and drug product strategy

  Developing early CMC, formulation, and drug product plans aligned with product goals, target product profiles, manufacturability, scalability, and long-term development needs.

• Delivery and formulation development advisory

  Supporting formulation strategy, delivery system design, process considerations, and experimental planning for complex biologics, vaccines, RNA-based products, and delivery-enabled therapies.

• Developability and manufacturability assessment

  Evaluating whether product concepts, formulations, delivery systems, or processes can support practical development, technology transfer, and future clinical or commercial needs.

• External innovation and technical due diligence

  Reviewing external platforms, assets, vendors, or collaboration opportunities to identify strengths, risks, data gaps, and key technical questions, and supporting technical discussions during partner meetings, vendor evaluations, investment reviews, or partnering pitches.

Mentoring, Training, and Strategic Advisory

Flexible support for founders, scientists, teams, and organizations needing experienced technical perspective without a full development program.

• Scientific and development mentoring

  Advising founders, scientists, and technical teams on advanced modalities, development strategy, CMC awareness, risk-based planning, and translation from research concepts into product-relevant plans.

• Technical training and capability building

  Designing and delivering tailored training programs on topics such as mRNA/LNP formulation, delivery technology principles, early CMC strategy, developability, and discovery-to-development planning.

• Technical plan, presentation, and pitch review

  Improving technical clarity, credibility, and development logic for internal reviews, investor discussions, partner meetings, grant applications, and accelerator programs.

• Prioritization, risk assessment, and decision support

  Helping teams organize complex technical issues into clear options, practical next steps, and communication for leadership, partners, or cross-functional stakeholders.